Geron CMO Aleksandra Rizo resigns; Faye Feller named new CMO

GERON CORP

Dr. Aleksandra Rizo resigns as EVP and CMO, effective July 8, 2022, to join a private discovery-stage biotech.
Rizo will remain as Senior Medical and Regulatory Advisor, assisting with IMerge Phase 3 trial data and potential NDA.
Dr. Faye Feller promoted to EVP and CMO effective July 9; she joined Geron in 2019 from Janssen.
Feller previously served as Study Responsible Physician for imetelstat's IMbark Phase 2 trial at Janssen.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Faye Feller

Executive Vice President and Chief Medical Officer

GERN · GERON CORP

Effective: 2022-07-09
Filed: June 15, 2022, 7:59 PM ET

Effective as of July 9, 2022, Faye Feller, M.D., will assume the duties and responsibilities of Executive Vice President and Chief Medical Officer of the Company.

Departed

Aleksandra Rizo

Executive Vice President and Chief Medical Officer

GERN · GERON CORP

Effective: 2022-07-08
Successor: Faye Feller
Filed: June 15, 2022, 7:59 PM ET

On June 9, 2022, Aleksandra Rizo, M.D., Ph.D., notified Geron Corporation (the “Company” or “Geron”) of her decision to resign from her position as Executive Vice President and Chief Medical Officer of the Company, with her last day of employment being July 8, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Faye Feller was appointed as Executive Vice President and Chief Medical Officer at GERON CORP.

Action: appointed
Role: Executive Vice President and Chief Medical Officer

Exact text from the filing

Effective as of July 9, 2022, Faye Feller, M.D., will assume the duties and responsibilities of Executive Vice President and Chief Medical Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Aleksandra Rizo resigned as Executive Vice President and Chief Medical Officer at GERON CORP.

Action: resigned
Role: Executive Vice President and Chief Medical Officer

Exact text from the filing

On June 9, 2022, Aleksandra Rizo, M.D., Ph.D., notified Geron Corporation (the “Company” or “Geron”) of her decision to resign from her position as Executive Vice President and Chief Medical Officer of the Company, with her last day of employment being July 8, 2022

View on SEC.gov

GERON CORP filing history →

Source: SEC EDGAR

accession 0001206774-22-001546

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.